As Global Chief Medical Officer, Dr. Richard Lanman is responsible for clinical studies, publications, and physician education at Guardant Health. Richard previously served as the Chief Medical Officer of Veracyte, where he managed collaborations with academic and community-based physician thought leaders. He also led the studies and publications resulting in broad managed care coverage for the Afirma thyroid cancer test. Previously, he served as Chief Medical Officer for two cardiovascular biodiagnostic companies, diaDexus and Atherotech. Prior to Atherotech, Richard was the medical director and senior vice president of San Jose Medical Group and a chief of quality at Kaiser Permanente. He completed his internship and residency at the University of California San Francisco, after receiving an MD from Northwestern University and a BS in chemistry from Stanford University, where he graduated Phi Beta Kappa.